FDA clears IND for clinical trial testing switchable CAR-T therapy in patients with autoimmune diseases, without chemotherapy (IMAGE)

Scripps Research Institute

FDA clears IND for clinical trial testing switchable CAR-T therapy in patients with autoimmune diseases, without chemotherapy

Caption

Kiah Zuniga, research assistant at Calibr-Skaggs, helps develop the novel sCAR-T therapy

Credit

Scripps Research

Usage Restrictions

Can be used with related coverage and with credit

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.